Source: StreetInsider

Press Release: Arcus : Arcus Biosciences to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

HAYWARD, Calif.--(BUSINESS WIRE)-- Arcus Biosciences (NYSE: RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, announced...

Read full article »
Annual Revenue
$100-500M
Employees
500-1.0K
Terry Rosen's photo - Co-Founder & CEO of Arcus

Co-Founder & CEO

Terry Rosen

CEO Approval Rating

90/100

Read more